| Announce Date | 09/30/2025 |
| EPS Normalized Actual | $-0.01 In Line |
| EPS GAAP Actual | $-0.01 In Line |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Nov 2025 | -0.11 | -42.45 | -0.11 | -0.11 | 1 |
| Nov 2024 | -0.02 | -233.5 | -0.02 | -0.01 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | -0.0106 | -0.0106 | 0B | NAN% | 0M |
| FQ2 2025 (May 2025) | -0.01 | -0.01 | 0B | NAN% | 0M |
| FQ1 2025 (Feb 2025) | -0.02 | -0.02 | 0B | NAN% | 0M |
| FQ4 2024 (Nov 2024) | -0.0102 | -0.0102 | 0B | NAN% | 0M |
| FQ3 2024 (Aug 2024) | 0 | 0 | 0B | NAN% | 0M |
| FQ2 2024 (May 2024) | -0.011 | -0.011 | 0B | NAN% | 0M |
| FQ1 2024 (Feb 2024) | -0.0226 | -0.0226 | 0B | NAN% | 0M |
| FQ4 2023 (Nov 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | -0.0219 | -- | -0.0219 | -0.0219 | 1 |
| FQ3 2027 (Aug 2027) | -0.0234 | -- | -0.0234 | -0.0234 | 1 |
| FQ2 2027 (May 2027) | -0.0234 | -- | -0.0234 | -0.0234 | 1 |
| FQ1 2027 (Feb 2027) | -0.0234 | -- | -0.0234 | -0.0234 | 1 |
| FQ4 2026 (Nov 2026) | -0.01245 | -- | -0.01245 | -0.01245 | 1 |
| FQ3 2026 (Aug 2026) | -0.0318 | 66.67 | -0.0318 | -0.0318 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Aug 2027) | 0B | -- | 0B | 0B | 0 |
| FQ2 2027 (May 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Feb 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Nov 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Aug 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | -0.0106 | -0.0106 | 100% | |
| FQ2 2025 (May 2025) | -0.01 | -0.01 | 100% | |
| FQ1 2025 (Feb 2025) | -0.02 | -0.02 | 100% | |
| FQ4 2024 (Nov 2024) | -0.0102 | -0.0102 | 100% | |
| FQ3 2024 (Aug 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (May 2024) | -0.011 | -0.011 | 100% | |
| FQ1 2024 (Feb 2024) | -0.0226 | -0.0226 | 100% | |
| FQ4 2023 (Nov 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (May 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Feb 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Nov 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Aug 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (May 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Feb 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Nov 2023) | $0B | $0B | $0M | NAN% |